JPMorgan Healthcare Leaders ETF (JDOC)
JDOC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 5 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -4,75% | ▼ -4,75% |
| 3M | ▲ +4,91% | ▲ +4,91% |
| 6M | ▲ +4,91% | ▲ +4,91% |
| YTD | ▲ +3,53% | ▲ +3,53% |
| 1Y | ▲ +10,01% | ▲ +10,97% |
| 3Y | · | · |
| 5Y | · | · |
| Maks | ▲ +3,27% | ▲ +9,56% |
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 61 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| AbbVie, Inc. | 00287Y109 | $712K | 7,85 | 2.838 | EC | US |
| Eli Lilly & Co. | 532457108 | $704K | 7,76 | 613 | EC | US |
| UnitedHealth Group, Inc. | 91324P102 | $531K | 5,85 | 1.281 | EC | US |
| Merck & Co., Inc. | 58933Y105 | $437K | 4,82 | 3.359 | EC | US |
| Johnson & Johnson | 478160104 | $437K | 4,82 | 1.706 | EC | US |
| AstraZeneca plc | · | $341K | 3,76 | 2.007 | EC | GB |
| Thermo Fisher Scientific, Inc. | 883556102 | $339K | 3,73 | 590 | EC | US |
| Bristol-Myers Squibb Co. | 110122108 | $324K | 3,57 | 4.962 | EC | US |
| Abbott Laboratories | 002824100 | $282K | 3,11 | 2.669 | EC | US |
| CVS Health Corp. | 126650100 | $257K | 2,83 | 2.458 | EC | US |
| Roche Holding AG | · | $256K | 2,82 | 586 | EC | CH |
| Novo Nordisk A/S | · | $237K | 2,61 | 5.014 | EC | DK |
| GSK plc | · | $224K | 2,47 | 8.605 | EC | GB |
| Stryker Corp. | 863667101 | $202K | 2,23 | 620 | EC | US |
| Danaher Corp. | 235851102 | $196K | 2,16 | 1.006 | EC | US |
| Cencora, Inc. | 03073E105 | $188K | 2,07 | 604 | EC | US |
| Argenx SE | · | $187K | 2,06 | 218 | EC | NL |
| Intuitive Surgical, Inc. | 46120E602 | $175K | 1,93 | 496 | EC | US |
| Edwards Lifesciences Corp. | 28176E108 | $157K | 1,73 | 1.827 | EC | US |
| IQVIA Holdings, Inc. | 46266C105 | $155K | 1,71 | 661 | EC | US |
| Teva Pharmaceutical Industries Ltd. | · | $145K | 1,60 | 4.084 | EC | IL |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $145K | 1,60 | 190 | EC | US |
| Novartis AG | · | $145K | 1,60 | 926 | EC | CH |
| Biogen, Inc. | 09062X103 | $142K | 1,56 | 699 | EC | US |
| Cardinal Health, Inc. | 14149Y108 | $137K | 1,51 | 597 | EC | US |
| Takeda Pharmaceutical Co. Ltd. | · | $117K | 1,29 | 3.400 | EC | JP |
| Centene Corp. | 15135B101 | $108K | 1,19 | 1.740 | EC | US |
| Hoya Corp. | · | $107K | 1,18 | 700 | EC | JP |
| Humana, Inc. | 444859102 | $106K | 1,16 | 290 | EC | US |
| Boston Scientific Corp. | 101137107 | $97K | 1,07 | 2.069 | EC | US |
| Fresenius SE & Co. KGaA | · | $94K | 1,04 | 1.831 | EC | DE |
| Insmed, Inc. | 457669307 | $88K | 0,97 | 894 | EC | US |
| Genmab A/S | · | $76K | 0,83 | 263 | EC | DK |
| Sartorius AG | · | $75K | 0,83 | 298 | EC | DE |
| Dyne Therapeutics, Inc. | 26818M108 | $75K | 0,82 | 2.968 | EC | US |
| Vertex Pharmaceuticals, Inc. | 92532F100 | $74K | 0,81 | 155 | EC | US |
| Spyre Therapeutics, Inc. | 00773J202 | $70K | 0,77 | 710 | EC | US |
| Neurocrine Biosciences, Inc. | 64125C109 | $67K | 0,73 | 399 | EC | US |
| Bridgebio Pharma, Inc. | 10806X102 | $66K | 0,73 | 822 | EC | US |
| Alnylam Pharmaceuticals, Inc. | 02043Q107 | $64K | 0,70 | 311 | EC | US |
| Align Technology, Inc. | 016255101 | $64K | 0,70 | 376 | EC | US |
| Charles River Laboratories International, Inc. | 159864107 | $60K | 0,66 | 259 | EC | US |
| CG oncology, Inc. | 156944100 | $56K | 0,62 | 791 | EC | US |
| Ascendis Pharma A/S | · | $53K | 0,59 | 218 | EC | DK |
| Alumis, Inc. | 022307102 | $52K | 0,57 | 1.834 | EC | US |
| LB Pharmaceuticals, Inc. | 50180M108 | $50K | 0,56 | 1.258 | EC | US |
| Disc Medicine, Inc. | 254604101 | $46K | 0,51 | 600 | EC | US |
| PTC Therapeutics, Inc. | 69366J200 | $45K | 0,49 | 658 | EC | US |
| Bicara Therapeutics, Inc. | 055477103 | $40K | 0,44 | 1.484 | EC | US |
| Arcus Biosciences, Inc. | 03969F109 | $39K | 0,43 | 1.384 | EC | US |
Rincian sektor
Dividen 4 pembayaran
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 16 Des. 2025 | $0,5120 |
| 24 Des. 2024 | $0,3280 |
| 16 Des. 2024 | $2,4890 |
| 19 Des. 2023 | $0,0800 |
Pemilik institusional (13F) 6 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | $5.353.127 | 84,53% | 88.196 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $449.318 | 7,10% | 7.460 | Saham | 30 Juni 2026 |
| Krilogy Financial LLC | $266.640 | 4,21% | 4.427 | Saham | 30 Juni 2026 |
| Sanctuary Advisors, LLC | $250.087 | 3,95% | 4.152 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $7.000 | 0,11% | 120 | Saham | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $6.384 | 0,10% | 106 | Saham | 30 Juni 2026 |